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Abstract
Chronic kidney disease patients on maintenance dialysis (CKD 5D) experience major morbidity and 
mortality. No data on survival in Maltese dialysis patients exist; therefore, the aim of this study was to 
rigorously examine survival statistics in a complete cohort of Maltese CKD 5D patients.
The study population was comprised of all incident chronic patients (N=328) starting dialysis at the 
renal unit, Mater Dei hospital, Msida, Malta, for 4 consecutive years (2009–2012). Each yearly cohort 
was analysed in detail up to 31st December 2017, providing up to 8 years follow-up. Demographics 
(male 65%; female 35%), aetiology of renal failure (diabetic kidney disease: n=191; 58.2%), comorbidities, 
transplant status, and death were documented. Data collection and follow up were completed and 
statistical analysis was performed on the aggregated cohorts with SPSS version 23 with censoring up 
to 31st December 2017.
The cumulative adjusted 5-year overall survival in Maltese CKD 5D patients was 0.36 and 0.25 at 8 
years. No statistical difference was observed according to the year of starting dialysis. Cox regression 
analysis showed that age and transplant status influenced survival. The unadjusted hazard of death 
increased by 3% for every 1-year increase in age and was increased by 7% if the patient did not receive 
a transplant, and overall 22% (n=72) of the entire cohort eventually received transplants.
This study reports an approximate 65% mortality at 5 years in Maltese haemodialysis patients, a poor 
prognosis that, despite optimal medical management, is consistent with worldwide reports.
INTRODUCTION
Chronic kidney disease (CKD) requiring dialysis 
carries a significantly high mortality rate.1 To date 
there have been no studies in the Maltese islands 
that have described the incidence and mortality 
of patients requiring renal replacement therapy 
(RRT). In this 8-year study, the survival of patients 
suffering from CKD-5D (estimated glomerular 
filtration rate [eGFR] <15mL/min/1.73m2) requiring 
RRT was measured. All incident dialysis cases of 
CKD requiring dialysis were initially reviewed at a 
single clinical centre providing a complete source 
of data for the Maltese archipelago.
Aims
 > To create an electronic register containing 
details and comorbidities of Maltese patients 
who started dialysis in view of CKD-stage 5D 
between 1st January 2009 and 31st December 
2012 at the renal unit, Mater Dei Hospital.
 > To note the survival duration, comorbidities, 
demographics, and transplant status of 
patients in the register.
 > To follow up survival outcomes till the 31st 
January 2017.
 > To determine survival outcomes and mortality 
indicators for patients on RRT, including renal 
transplant recipients. 
Ethics Approval
Permission was granted by the clinical chairman, 
central executive officer, data protection officer, 
and consultant nephrologists at Mater Dei 
Hospital; the Department of Health Information 
Research (DHIR); and the Faculty Research Ethics 
Committee, University of Malta (FREC). Patient 
consent was deemed unnecessary by the FREC 
as data was gathered from secondary sources 
and interpreted in a nonidentifiable manner.
Manual records kept at the renal unit, Mater 
Dei Hospital, detailing information on name, 
identification number, and date of start dialysis 
from the 1st January 2008 to the 31st December 
2012 were reviewed and transferred to an 
electronic medium (Microsoft® Excel 2007, 
Redmond, Washington, USA). Information on 
demographics, age of start dialysis, duration of 
dialysis, comorbidities, transplant status, aetiology 
of renal failure, cause of death, and survival were 
gathered from hospital electronic and manual 
records (Isoft Clinical Manager®, Sydney, Australia; 
Electronic Case Summaries) and DHIR databases. 
Electronic records for the year 2008 were 
incomplete as they were not yet established. The 
final data set contained nonidentifiable data.
MATERIALS AND METHODS
Methodology of data collection and interpretation 
were reviewed by a consultant nephrologist, 
statistician, and trainee in general practice. A 
pilot study was carried out involving ten patients 
from each year reviewing survival from 1st January 
2009 to 31st December 2012. Criteria for inclusion 
and exclusion were modified accordingly. The 
eGFR was calculated using the ‘Modification of 
Diet in Renal Disease’ formula.
Inclusion criteria:
 > Starting dialysis between 1st January 2009 and 
31st January 2012 or receiving a new kidney 
transplant.
 > Maltese national.
 > History of prior CKD stage 5 (eGFR ≤15mL/
min/1.73m2 >3 months) 
Exclusion criteria:
 > Starting dialysis outside the timeframe of 1st 
January 2009 and 31st January 2012.
 > Prior history of transplantation before starting 
dialysis.
 > Foreign national.
 > Acute kidney injury requiring dialysis eGFR 
>15mL/min/1.73m2 
Defining Renal Replacement Therapy 
Start Date
Survival figures were taken from the first day of 
RRT with dialysis or pre-emptive transplant.
Sample Size
At the renal unit, Mater Dei Hospital, 613 patients 
were started on dialysis from 1st January 2009 to 
31st January 2012. Of these patients, 328 cases 
fitted the inclusion criteria for the study.
Statistical Methods
The age-adjusted survival probabilities (with 
95% confidence intervals [CI]) of all incident 
end-stage renal disease patients receiving RRT 
and patients receiving a first transplant between 
1st January 2009 and 31st December 2012 were 
calculated using the Kaplan-Meier method. 
However, this method can only investigate the 
effect of a single categorical confounding factor 
on survival duration. In order to adjust for several 
continuous and categorical confounding factors, 
the proportional hazards Cox regression model 
was used. 
From the electronic case summaries, 60 
explanatory variables were identified as possible 
predictors of the survival duration of renal patients. 
To identify the significant predictors of survival 
duration a Cox regression model was fitted using 
a forward Wald procedure. The parsimonious 
model identified nine significant predictors which 
included for example the age of the patient and 
transplant status (Table 1).
For each covariate the model provides a hazard 
ratio (HR), which is the ratio of the hazard rates 
corresponding to the conditions described by 
two categories of the covariate. Age was adjusted 
initially to <60 years (n=109), 60–70 years of age 
(n=97), 71–95 years (n=122), and then in a second 
analysis at 40 years of age: <40 years (n=28); >40 
years (n=300). Multivariate logistic regression 
analysis was performed to identify independent 
predictors of mortality which revealed seven 
factors that did not show variation in responses. A 
95% confidence level was used when computing 
CI and a 0.05 level of significance was used when 
conducting statistical tests. 
Patients were followed up to 31st December 2017 
providing an 8-year time frame. For the analysis 
of patient survival on RRT, the first day of RRT 
was taken as the starting point and the event 
studied was death. Adjustments were made for 
age, sex, cause of renal failure, transplant status, 
and confounding variables on mortality (Table 1). 
SPSS version 25 was used for statistical analysis.
Covariates Sample size 
(n)
B SE Wald Df p-value HR 95% CI for hazard 
ratio
Lower Upper
Transplanted1 71 -2.334 0.347 45.258 1 0.000 0.097 0.049 0.191
Age (overall)1 328 0.029 0.006 20.543 1 0.000 1.029 1.016 1.042
Age group >701 108 aliased
Age group <601 97 -0.614 0.184 11.148 1 0.001 0.541 0.378 0.776
Age group 60-701 123 -0.375 0.155 5.897 1 0.015 0.687 0.508 0.930
Alcoholism1 3 1.290 0.604 4.556 1 0.033 3.632 1.111 11.869
Gout1 18 -0.956 0.359 7.100 1 0.008 0.384 0.190 0.777
Liver disease1 3 1.617 0.646 6.261 1 0.012 5.037 1.420 17.872
Nephrolithiasis1 3 1.476 0.593 6.195 1 0.013 4.374 1.368 13.979
Renal artery stenosis1 1 2.463 1.030 5.725 1 0.017 11.744 1.561 88.343
Transplant failure1 8 1.562 0.561 7.747 1 0.005 4.766 1.587 14.313
COPD2 31 0.540 0.220 6.100 1 0.01 1.71 1.120 2.630
Table 1: Cox regression analysis of hazard ratios and 95% confidence interval for renal replacement therapy: Specific 
subgroups adjusted to age.
B: constant coefficient; COPD: chronic obstructive pulmonary disease; Df: degrees of freedom; HR: hazard ratio; SE: 
standard error. 
Methodology for Unadjusted Yearly 
Incidences per Million Population 
Rates of Dialysis Dependent Chronic 
Kidney Disease Based on the Maltese 
Population 
Data on the number of the Maltese population 
was gathered from the National Statistics Office 
(NSO) website and the unadjusted incident yearly 
incidence rate of CKD requiring dialysis per 
million population (pmp) was calculated (number 
of incident dialysis patients ÷ total population × 
1,000,000).2
End of year population estimates for the Maltese 
population were; 2009: 395,075; 2010: 395,850; 
2011: 397,244; 2012: 398,898.2
Methodology for Incident Patient 
Survival and Censoring
The dialysis patient population included all 
patients who started dialysis between 1st January 
2009 and 31st December 2017. Patients who 
undertook or attempted a renal transplant were 
not censored from the study and the 4-year 
incident data was combined (2009–2012). 
Measured outcomes were mortality at 1 month, 
1 year after 1 month, 5 years, and 8 years after 
starting dialysis. Data was adjusted according 
to age (<60 years: n=108; 32.9%, 60–70 years: 
n=29.6%, >70 years: n=123; 37.5%) and gender 
did not influence survival outcomes in this group.
Methodology of Median Life 
Expectancy 
Several Cox regression models were fitted to 
relate survival probabilities to dialysis duration 
for different age groups (<60 years, 60-70 years, 
>70 age group) for incident patients starting RRT 
from 2009–2012. The patient inclusion criteria 
are the same as those of the incident patient 
cohort described above. Patients were followed 
until death and those who survived till the end of 
the study period were right censored. Median life 
expectancy is the age when the survival function 
reaches a survival probability of 0.5. 
RESULTS
Demographics
The mean age of patients starting RRT was 63.6 
ranging from 19 to 91 years. Of these patients, 
58.2% cases had diabetes as their primary renal 
diagnosis (n=191). The majority of patients 
starting RRT were men (65.2%; n=214) with an 
average age of 63, of which 56.5% (n=121) were 
diabetic (Table 2). Causes of renal failure included: 
diabetes (58.2%); unknown (20.4%); polycystic 
kidney disease (PCKD) (6.7%); and other (17.6%).
Other included: focal segmental 
glomerulosclerosis: n=22; obstructive 
uropathy: n=13; urinary tract infections: n=3; 
chronic lymphocytic leukaemia infiltration: 
n=1; IgA nephropathy: n=3; membranous 
Categorical variables
Yes No
Diabetes 57.3% (n=188) 42.7% (n=140)
Gender (male) 65.2% (n=214) 34.8% (n=34)
Renal transplant recipient 21.6% (n=71) 78.4% (n=257)
Continuous variables
Mean Standard deviation
Age (years) 63.57 14.85
Survival Duration (days) 1286.66 994.88
Table 2: Baseline characteristics.
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Figure 1: Adjusted cumulative incidence of death and receiving a kidney transplant according to age: incident 
dialysis patients from Day 1.
glomerulonephritis: n=2; microscopic polyangiitis: 
n=1; multiple myeloma: n=3; hypertension: n=1; 
unspecified glomerulonephritis: n=3; lupus 
nephritis: n=3; and unspecified vasculitis: n=3.
Incidence (New Renal Replacement 
Therapy) Rates per Year
The unadjusted yearly incidences pmp rates 
based on the Maltese population were:2
 > 2009 (n=90): 228 pmp.
 > 2010 (n=84): 212 pmp.
 > 2011 (n=72): 181 pmp.
 > 2012 (n=82): 206 pmp. 
Across the 4 years, there were on average two 
males for every female requiring dialysis. The 
Chi square test showed that these percentages 
(65.2% for males and 34.8% for females) vary 
marginally between the age groups because 
the p-value (0.213) exceeds the 0.05 level of 
significance.
Incidence of Renal Transplants per Year
The unadjusted incident renal transplant rates 
pmp years rates were:2
 > 2009 (n=24): 61 pmp.
 > 2010 (n=15): 38 pmp.
 > 2011 (n=20): 50 pmp.
 > 2012 (n=12): 30 pmp. 
Overall the average rate of transplantation for 
the Maltese population was 44.75 pmp over the 
4-year period totalling 71 transplants.
Overall Survival
The unadjusted survival rates following start of 
RRT was 94% (standard error 0.013) at 1 month; 
72% (standard error 0.025) at 1 year after 1 month; 
36% (standard error 0.027) at 5 years; and 25% at 
8 years (standard error 0.028). At the end of the 
study almost 70% of the cohort passed away, 21% 
were transplanted, and 11% remained on dialysis 
(Figure 1).
Median Life Expectancy
In the >70 age group, 50% of the patients starting 
RRT survived 1,040 days (2.84 years). Median life 
expectancy for the 60–70 age group was 1,450 
days (3.96 years), whereas for the <60-year age 
group this was 1,850 days (5.06 years). 
Covariates Influencing Survival
Seventy-two variables were included into the Cox 
regression model. On comparing covariates age, 
transplant status (p<0.001, 95% CI: 0.049–0.191), 
transplant failure (p=0.005, 95% CI: 1.59–14.31), 
nephrolithiasis (p=0.013, 95% CI: 1.37–13.98), renal 
artery stenosis (p=0.017; 95% CI: 1.56–88.34), 
gout (p=0.008; 95% CI: 0.19–0.78), liver disease 
(p=0.012; 95%: 1.42–17.87), and alcoholism 
(p=0.033; 95% CI: 1.11–11.87) influenced survival 
(Table 1). On adjusting survival to age 40, chronic 
obstructive pulmonary disease (p=0.014; 95% CI: 
1.12–2.63) was also significant (Table 1).
Age and Hazard of Death
Cox regression analysis demonstrated that 
for every 1 year increase, the hazard of death 
increased by 3% (p<0.0001%; 95% CI: 1.016–1.042) 
(Table 1).
Hazard Ratio According to Year of 
Dialysis
The HR varies marginally from 1, indicating that 
the hazard of death is not changing significantly 
throughout the 4 years.
Survival by Gender
The log-rank test showed that the survival 
probability functions did not vary significantly 
between the two genders (χ2=0.018; degrees of 
freedom (df)=1; p=0.894). 
DISCUSSION
The Maltese population has a high incidence of 
dialysis when compared to other countries in the 
European Renal Association - European Dialysis 
and Transplant Association (ERA-EDTA) registry 
2012 annual report, with unadjusted rates of 
dialysis surpassed only by Greece (210.0 pmp) 
and Portugal (220.0 pmp), reflecting a higher 
trend for southern European countries.1 Rates 
of incident dialysis cases remained relatively 
stable over the 4 years. Compared to the average 
unadjusted transplant rates in Europe, Malta’s 
annual rates (30.0 pmp) were slightly above 
average (28.2 pmp), and comparable to Slovenia 
(30.6 pmp) and Poland (30.3 pmp).1
The overall increase in the hazard of death by 3% 
(HR: 1.03), and the hazard of death for a patient 
who received a kidney transplant is 0.097 times 
the hazard of a patient not receiving a kidney 
transplant. This implies that the hazard of death 
for a patient not receiving a kidney transplant is 
10.31 times that of a patient receiving a kidney 
transplant. This result does not eliminate the bias 
of eligibility for renal transplantation. Wolfe et al.,3 
established that eligibility for renal transplantation 
confers a 50% reduced risk of death; however, this 
study has shown that transplant failure confers an 
increased risk of mortality as well.
European data has identified an increase in 
PCKD requiring RRT, attributable to a decrease in 
cardiovascular mortality in this group of patients. 
In the Maltese population, PCKD was classified 
as the second most common cause of end-stage 
kidney disease requiring RRT, while in European 
data PCKD ranks fourth.4 This may be attributable 
to a significant proportion (24%) of cases for which 
the cause remains unknown. Chronic obstructive 
pulmonary disease has shown reproducibility as 
a factor that increases mortality in patients with 
advanced kidney disease.5,6
Diabetic nephropathy has been identified as the 
number one cause of end-stage kidney disease 
in Europe.1 The latter has also been implicated as 
the major contributor to CKD requiring dialysis in 
this study. Malta has a predominantly overweight 
population with a 10% national prevalence 
of diabetes.7,8 Interestingly, diabetes did not 
influence mortality in this cohort possibly due to 
relatively small numbers, although this has been 
established in other studies.9,10
The emergence of gout as a protective marker 
(HR: 0.34; 95% CI: 0.19–0.78) may reflect better 
nutritional status in these patients, but since neither 
serum albumin nor anthropometric data were 
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studied, this observation could just be a statistical 
aberration. Gout is associated with a higher 
cardiovascular risk in the general population; 
however, further studies are needed.11,12,13
LIMITATIONS
Limitations included BMI, smoking status, socio-
economic status, and biomarkers that influence 
survival and treatment which were not included 
in the regression analysis. Seven comorbidities 
were not included in the regression analysis in 
view of lack of variability. Data was collected 
from secondary sources and was not adjusted to 
RRT modality (haemodialysis versus peritoneal 
dialysis). Cause of death was not included due to 
variability in reporting.
CONCLUSION
Malta had the third highest unadjusted incident 
rate of dialysis dependent CKD compared to 
other European Union (EU) countries in 2012. The 
largest contributor leading to dialysis is diabetes 
and should be the focus of prevention and 
management. CKD requiring RRT incident rates 
appeared stable with 22% of the cases receiving a 
transplant. Renal transplant rates were comparable 
to the EU average in 2012 but on the decrease 
in trend. Although transplantation is associated 
with increased survival it is accompanied by an 
increased mortality when failure occurs. Diabetes 
did not appear to influence survival in this group.
View publication stats
